Roivant Sciences

Roivant Sciences

Roivant Sciences

Focused on the late-stage clinical development and commercialization of nonstrategic, deprioritized or under-resourced drug candidates.
Founded
2014
Raised
$1.3B
Follow us
Alexa global traffic share